+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides - 2021 to 2025

  • ID: 5311169
  • Report
  • December 2021
  • Region: Global
  • 357 Pages
  • Howe Sound Research

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Agilent
  • Binx Health
  • Bio-Rad Laboratories, Inc
  • ERS Genomics
  • Illumina

Report Overview:

CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere. A new COVID test is already available.

Will this disruptive technology change the world of In Vitro Diagnostics? What is the impact on Clinical Laboratories? How will social norms be affected?

The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size out to 2025. 

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Agilent
  • Binx Health
  • Bio-Rad Laboratories, Inc
  • ERS Genomics
  • Illumina

CRISPR Gene Detection Markets - Strategic Situation Analysis 

  • Guide for Executives, Marketing, Sales and Business Development Staff 
  • Guide for Management Consultants and Investment Advisors 

1. Introduction and Market Definition 
1.1 CRISPR Gene Detection Definition In This Report 
1.1.1 Research 
1.1.2 Clinical Laboratory 
1.1.3 Consumer Diagnostics 
1.1.4 Public Service 
1.1.5 Other 
1.2 CRISPR 
1.2.1 What is CRISPR 
1.2.2 What is Gene Detection? 
1.2.3 CRISPR and Diagnostics 
1.2.4 The Sizes of Genomes 
1.3 Market Definition 
1.3.1 Revenue Market Size 
1.4 U.S. Medical Market and laboratory Testing - Perspective  
1.4.1 U.S. Medicare Expenditures for laboratory testing 

2. Market Overview 
2.1 Market Participants Play Different Roles  
2.1.1 Instrument Manufacturer  
2.1.2 Independent lab specialized/esoteric 
2.1.3 Independent lab national/regional 
2.1.4 Independent lab analytical 
2.1.5 Public National/regional lab  
2.1.6 Hospital lab 
2.1.7 Physician lab 
2.1.8 DTC Lab 
2.1.9 Sequencing Labs 
2.1.10 Audit body  
2.2 Genetic Material Detection Markets, Examples and Discussion  
2.2.1 Research Markets  
2.2.2.1 Research Funding and Capital Expense 
2.2.2.2 The Research Role of CRISPR  
2.2.3 Clinical Laboratories - Accuracy, Cost and Speed 
2.2.3.1 Multiplexing in the Lab and at the Point of Care 
2.2.4 Consumer Diagnostics 
2.2.4.1 The CRISPR Consumer  
2.2.4.2 Why Consumers Like Multiplexing 
2.2.5 Public Service Markets 
2.2.5.1 Public Health 
2.2.5.2 Public Security  
2.2.5.3 Environmental Monitoring 
2.2.6 AgriBio and Other Markets  
2.2.6.1 AgriBio 
2.2.6.2 Other Uses for CRISPR Gene Detection 
2.3 Industry Structure 
2.3.1 The Biotechnology Industry  
2.3.2 In Vitro Diagnostics Industry 
2.3.2.1 Cannabilization, PCR and In Vitro Diagnostics 
2.3.3 The Food Industry  

3. Market Trends 
3.1 Factors Driving Growth 
3.1.1 Cost, Accuracy and Speed 
3.1.2 The Economies of Multiplexing with Nucleic Acids 
3.1.3 The New Agriculture 
3.1.4 Pandemics and Pathogens 
3.1.5 Health and Self - A Sea Change in Healthcare 
3.2 Factors Limiting Growth  
3.2.1 Ubiquitous PCR 
3.2.2 The Shrinking Cost of All Things Genetic  
3.2.3 Wellness has a downside  
3.2.4 The Limits of Detection 

4. CRISPR Recent Developments 
4.1 Recent Developments - Importance and How to Use This Section 
4.1.1 Importance of These Developments 
4.1.2 How to Use This Section  

  • CRISPR SARS-CoV-2 Test Could be used for Asymptomatic Screening 
  • Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test 
  • Pandemic Accelerates Development of CRISPR Diagnostics 
  • COVID Assays Use CRISPR and Smartphones  
  • ERS Genomics Licenses CRISPR Patents to Vivlion 
  • Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test 
  • ERS Genomics, FASMAC Sign Deal to Commercialize CRISPR-Cas9 Research Reagents 
  • The Nobel Prize in Chemistry 2020 
  • Caspr Biotech Developing COVID Dx  

5. Key Companies 

  • 10x Genomics, Inc 
  • Aelian Biotechnology  
  • Agilent  
  • Axxam  
  • Beckman Coulter Diagnostics 
  • Becton, Dickinson and Company 
  • Binx Health 
  • bioMérieux Diagnostics  
  • Bio-Rad Laboratories, Inc  
  • Caspr Biotech  
  • ERS Genomics  
  • FASMAC  
  • Illumina 
  • Janssen Diagnostics  
  • Locus Biosciences 
  • Mammoth Biosciences 
  • NRGene 
  • Roche Molecular Diagnostics 
  • Sherlock Biosciences 
  • Thermo Fisher Scientific Inc.  
  • Vivlion 

6. The Global Market for CRISPR Gene Detection and Diagnostics 
6.1 Global Market Overview by Country  
6.1.1 Table - Global Market by Country 
6.1.2 Chart - Global Market by Country 
6.2 Global Market by Application - Overview  
6.2.1 Table - Global Market by Application  
6.2.2 Chart - Global Market by Application - Base/Final Year Comparison 
6.2.3 Chart - Global Market by Application - Base Year  
6.2.4 Chart - Global Market by Application - Final Year 
6.2.5 Chart - Global Market by Application - Share by Year  
6.2.6 Chart - Global Market by Application - Segment Growth  
6.3 Global Market Organism - Overview  
6.3.1 Table - Global Market by Organism 
6.3.2 Chart - Global Market by Organism - Base/Final Year Comparison  
6.3.3 Chart - Global Market by Organism - Base Year 
6.3.4 Chart - Global Market by Organism - Final Year 
6.3.5 Chart - Global Market by Organism - Share by Year  
6.3.6 Chart - Global Market by Organism - Segment Growth 

7. Global CRISPR Gene Detection and Diagnostics Markets - By Application 
7.1 Research  
7.1.1 Table Research - by Country  
7.1.2 Chart - Research Growth 
7.2 Clinical Laboratory 
7.2.1 Table Clinical Laboratory - by Country 
7.2.2 Chart - Clinical Laboratory Growth 
7.3 Clinical Consumer  
7.3.1 Table Clinical Consumer - by Country  
7.3.2 Chart - Clinical Consumer Growth 
7.4 Public Service 
7.4.1 Table Public Service - by Country 
7.4.2 Chart - Public Service Growth 
7.5 Agriculture/Other 
7.5.1 Table Agriculture/Other - by Country 
7.5.2 Chart - Agriculture/Other Growth 

8. Global CRISPR Gene Detection and Diagnostics Markets - by Organism 
8.1 Human 
8.1.1 Table Human - by Country 
8.1.2 Chart - Human Growth 
8.2 Pathogen 
8.2.1 Table Pathogen - by Country 
8.2.2 Chart - Pathogen Growth  
8.3 Other Organism 
8.3.1 Table Other Organism - by Country 
8.3.2 Chart - Other Organism Growth 

9. Vision of the Future of CRISPR Gene Detection and Diagnostics 

Appendices 

  • United States Medicare System: January 2021 laboratory Fees Schedule  
  • The Whole Genome Sequence of SARS-CoV-2 
  • GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts 
  • Methodology 
  • Authors 
  • Sources 

List of Tables
Table 1 The Base Pairs 
Table 2 Lab Spending 2014 to 2024 
Table 3 Market Players by Type 
Table 4 The Different Markets for Genetic Detection  
Table 5 Key Roles for CRISPR in Public Service 
Table 6 Other Uses for CRISPR Gene Detection 
Table 7 The Factors Driving Growth 
Table 8 Factors Limiting Growth 
Table 9 Global Market by Region  
Table 10 Global Market by Application 
Table 11 Global Market by Organism 
Table 12 Research by Country 
Table 13 Clinical Laboratory by Country 
Table 14 Clinical Consumer by Country 
Table 15 Public Service by Country  
Table 17 Agriculture/Other by Country 
Table 18 Human by Country 
Table 19 Pathogen by Country 
Table 20 Other Organism by Country 
Table 21 2021 Clinical Lab Fee Schedule 
Table 22 List of GLOBAL SEQUENCING LOCATIONS 

List of Figures
Figure 1 Size of Genome for Various Species 
Figure 2 Clinical Lab Spending 2014 to 2024 
Figure 3 Cost To Sequence a Human Genome 
Figure 4 Base Year Country Market Share Chart 
Figure 5 Global Market by Application - Base vs. Final Year 
Figure 6 Global Market by Application Base Year  
Figure 7 Global Market by Application Final Year  
Figure 8 Application Type Share by Year  
Figure 9 by Application Segment Growth 
Figure 10 by Organism - Base vs. Final Year 
Figure 11 by Organism Market Base Year 
Figure 12 by Organism Market Final Year 
Figure 13 by Organism Share by Year 
Figure 14 by Organism Segment Growth 
Figure 15 Research Growth 
Figure 16 Clinical Laboratory Growth 
Figure 17 Clinical Consumer Growth 
Figure 18 Public Service Growth 
Figure 20 Agriculture/Other Growth 
Figure 21 Human Growth 
Figure 22 Pathogen Growth  
Figure 23 Other Organism Growth 

Note: Product cover images may vary from those shown

Loading
LOADING...

  • 10x Genomics, Inc 
  • Aelian Biotechnology  
  • Agilent  
  • Axxam  
  • Beckman Coulter Diagnostics 
  • Becton, Dickinson and Company 
  • Binx Health 
  • Bio-Rad Laboratories, Inc  
  • bioMérieux Diagnostics  
  • Caspr Biotech  
  • ERS Genomics  
  • FASMAC  
  • Illumina 
  • Janssen Diagnostics  
  • Locus Biosciences 
  • Mammoth Biosciences 
  • NRGene 
  • Roche Molecular Diagnostics 
  • Sherlock Biosciences 
  • Thermo Fisher Scientific Inc.  
  • Vivlion 
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll